Company / Depreciation & Amortization
AMICUS THERAPEUTICS, INC. Depreciation & Amortization History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$7.5M
FY2025
5-year range
$5.3M / $8.5M
FY2021-FY2025
Trend
-12.7%
vs FY2024
Sector context
#73 of 168
Health Care
What the data says
At $7M, AMICUS THERAPEUTICS, INC.'s depreciation & amortization ranks #96 of 168 in the Health Care sector. Depreciation & Amortization has fluctuated over the past 9 years, ranging from $4M in FY2017 to $9M in FY2020.
Based on SEC 10-K filings.
$7M in FY2025 with a 5-year CAGR of -3.4%.
Improved from $8M to $7M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +11.8%
- 5-Year CAGR
- -3.4%
- 10-Year CAGR
- -
Sector benchmark
#96 of 168 in Health CareTop 57% of 168This company $7.5M Sector average $212.9M
▼
-96.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.4%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 12.7% year-over-year.
- Ranks #73 out of 168 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.5M | -12.7% |
| FY2024 | $8.5M | +8.6% |
| FY2023 | $7.9M | +47.4% |
| FY2022 | $5.3M | -14.0% |
| FY2021 | $6.2M | -29.8% |
| FY2020 | $8.8M | +85.3% |
| FY2019 | $4.8M | +13.3% |
| FY2018 | $4.2M | +17.3% |
| FY2017 | $3.6M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026